Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHIELD Pilot for myocardial injury after non-cardiac surgery
ACTRN12625000146493Phase 2Not yet recruiting
- Sponsor
- The University of Queensland
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in myocardial injury after non-cardiac surgery (MINS) comparing Forxiga with Placebo (2 arms). Primary endpoints: Evaluation of recruitment capability and sample characteristics, Evaluation and refinement of data collection procedures and outcome measures and 1 more. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
dapagliflozin
03
Conditions
myocardial injury after non-cardiac surgery (MINS)
Beyond the preview
Go deeper on ACTRN12625000146493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000146493.